Efficacy of Voriconazole Loaded Spanlastics Gel Versus Clotriamazole Cream on Treating Vulvovaginal Candidasis
NCT06392529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2024-08-07
Summary
To investigate and compare the efficacy of voriconazole loaded spanlastics (VCZ loaded SPs) optimum gel formula (F2 VCZ loaded SP gel) versus Clotrimazole cream in treating candida albicans causing vulvovaginal candidiasis for different durations of 3 days and 5 days.
Conditions
Interventions
- DRUG
-
Voriconazole Powder
The drug will be topically applied for vagina of patients suffering from vaginal Candidasis albican
Sponsors & Collaborators
-
Beni-Suef University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-10
- Primary Completion
- 2024-06-15
- Completion
- 2024-06-30
- FDA Drug
- Yes
Countries
- Egypt
Study Locations
More Related Trials
-
Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
NCT01137292 ·Status: COMPLETED
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001810 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT02267382 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections
NCT06680544 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
NCT01092832 ·Status: TERMINATED ·Phase: PHASE3
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001757 ·Status: COMPLETED ·Phase: PHASE3
-
Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.
NCT05895162 ·Status: UNKNOWN ·Phase: NA
-
Bioavailability of Voriconazole
NCT02110316 ·Status: WITHDRAWN ·Phase: PHASE4
-
Antifungal Use in Oncohematological Neutropenic Patients
NCT00386802 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
NCT02631954 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Boric Acid vs. Terconazole in Treatment of RVVC
NCT04208555 ·Status: UNKNOWN ·Phase: NA
-
Voriconazole to Treat Fungal Infections
NCT00001940 ·Status: COMPLETED ·Phase: PHASE3
-
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
NCT03731169 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
NCT00288197 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
NCT03987620 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen
NCT03760276 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.
NCT03260634 ·Status: UNKNOWN
-
Therapeutic Drug Monitoring of Voriconazole
NCT00890708 ·Status: COMPLETED ·Phase: NA
-
Voriconazole Blood Levels and Toxicity
NCT00359541 ·Status: COMPLETED
-
Nasal Antisepsis for C. Auris Prevention
NCT06282510 ·Status: RECRUITING ·Phase: PHASE4
-
MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
NCT01497223 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of the Vacucis Candida® Autovaccine
NCT05289375 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients
NCT01418846 ·Status: COMPLETED
-
Pharmacokinetics of Two Different Formulation of Voriconazole
NCT02912156 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations
NCT00673348 ·Status: UNKNOWN